EGFR and non-small cell lung carcinoma: In this respect, it has been shown that cell lines representing different EGFR-addicted cancer types, including NSCLC, may under therapeutic stress by TKIs use autophagy to eliminate the drugs and survive the treatment, while inhibitors of autophagy may augment the growth inhibitory effect of EGFR-TKIs [246,247,248,249].